The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Precision medicine in recurrent glioblastoma: A feasibility trial conducted by the Ivy Foundation Early Phase Clinical Trials Consortium.
 
Michael Prados
Honoraria - Actelion
Consulting or Advisory Role - Actelion
Research Funding - Genentech/Roche (Inst); Nativis (Inst); Novartis (Inst)
 
John G. Kuhn
Consulting or Advisory Role - Azaya Therapeutics; TG Therapeutics
Speakers' Bureau - Amgen
 
Howard Colman
Consulting or Advisory Role - CytRx Corporation; Genentech; Novocure; Omniox; Oxigene; Roche; Upsher-Smith
Research Funding - Newlink Genetics; Plexxikon
 
Timothy Francis Cloughesy
Consulting or Advisory Role - Abbvie; Agios; Amgen; Celgene; Celldex; cortice; CytRx Corporation; Lpath; Nektar; NewGen Therapeutics; Novartis; Novocure; Oxigene; proximagen; Roche/Genentech; Stemcycle; Tocagen; Upsher-Smith; VBL Therapeutics; wellcome trust
 
Susan Marina Chang
Consulting or Advisory Role - Neonc Technologies
Research Funding - Novartis (Inst); Quest diagnostics (Inst); Schering-Plough Research Institute (Inst)
 
Nicholas A. Butowski
No Relationships to Disclose
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I)
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celldex; Deciphera; Foundation Medicine; Genentech/Roche; Vascular Biogenics
Research Funding - Deciphera; EMD Serono; Lilly; Novartis; Sanofi
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; Angiochem; AstraZeneca; Cavion; Celldex; Exelixis; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; Midatech Pharma; Momenta Pharmaceuticals; Novartis; Novocure; Regeneron; Sanofi; Sigma-Tau; Vascular Biogenics
Speakers' Bureau - Merck
 
Keith L. Ligon
Consulting or Advisory Role - Midatech Pharma
Research Funding - Plexxikon
Patents, Royalties, Other Intellectual Property - Molecular Diagnostics Assay Patent
 
Ingo K. Mellinghoff
No Relationships to Disclose
 
Andrew S. Chi
No Relationships to Disclose
 
Joanna J Phillips
No Relationships to Disclose
 
Annette M Molinaro
No Relationships to Disclose
 
Rebecca Halperin
No Relationships to Disclose
 
Nhan Tran
No Relationships to Disclose
 
Michael E. Berens
No Relationships to Disclose
 
John D. Carpten
Consulting or Advisory Role - Ashion Analytics
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.
 
David W. Craig
No Relationships to Disclose
 
Sara A. Byron
No Relationships to Disclose